• Report SKU:SKU: HVR3415
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research Sources
1.4.2 Primary Research Sources
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Viral Inactivation Market by Product
5.1 Introduction
5.2 Viral Inactivation Systems and Accessories
5.3 Services
5.4 Kits and Reagents

6 Viral Inactivation Market by Method
6.1 Introduction
6.2 Solvent Detergent Method
6.3 Radiation method
6.4 pH Concentration method
6.5 Pasteurization
6.6 Alkylating agent method

7 Viral Inactivation Market by Application
7.1 Introduction
7.2 Vaccines and Therapeutics
7.3 Tissues and Tissue Products
7.4 Stem Cell Products
7.5 Cellular and Gene Therapy Products
7.6 Blood and Blood Products

8 Viral Inactivation Market by End User
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Hospitals
8.4 Contract Research Organizations
8.5 Blood Banks
8.6 Academic Research Institutes

9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 South America
9.4.1 Argentina
9.4.2 Brazil
9.4.3 Venezuela
9.4.4 Chile
9.4.5 Peru
9.5 Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Qatar
9.5.4 Iran
9.5.5 South Africa
9.5.6 Rest of Middle East & Africa

10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiles
11.1 Wuxi Pharmatech (Cayman) Inc
11.2 Viral Inactivated Plasma Systems SA
11.3 Texcell Inc
11.4 SGS SA
11.5 Sartorius AG
11.6 Rad Source Technologies Inc
11.7 Parker Hannifin Corporation
11.8 Merck KGAA
11.9 Danaher Corporation
11.10 Clean Cells Inc
11.11 Charles River Laboratories International Inc

12 Appendix

13 Disclaimer

List of Tables
Table 1 Global Viral Inactivation Market Analysis, by Region, (2017-2027) ($MN)
Table 2 Global Viral Inactivation Market Analysis, by Product, (2017-2027) ($MN)
Table 3 Global Viral Inactivation Market Analysis, by Viral Inactivation Systems and Accessories, (2017-2027) ($MN)
Table 4 Global Viral Inactivation Market Analysis, by Services, (2017-2027) ($MN)
Table 5 Global Viral Inactivation Market Analysis, by Kits and Reagents, (2017-2027) ($MN)
Table 6 Global Viral Inactivation Market Analysis, by Method, (2017-2027) ($MN)
Table 7 Global Viral Inactivation Market Analysis, by Solvent Detergent Method, (2017-2027) ($MN)
Table 8 Global Viral Inactivation Market Analysis, by Radiation method, (2017-2027) ($MN)
Table 9 Global Viral Inactivation Market Analysis, by pH Concentration method, (2017-2027) ($MN)
Table 10 Global Viral Inactivation Market Analysis, by Pasteurization, (2017-2027) ($MN)
Table 11 Global Viral Inactivation Market Analysis, by Alkylating agent method, (2017-2027) ($MN)
Table 12 Global Viral Inactivation Market Analysis, by Application, (2017-2027) ($MN)
Table 13 Global Viral Inactivation Market Analysis, by Vaccines and Therapeutics, (2017-2027) ($MN)
Table 14 Global Viral Inactivation Market Analysis, by Tissues and Tissue Products, (2017-2027) ($MN)
Table 15 Global Viral Inactivation Market Analysis, by Stem Cell Products, (2017-2027) ($MN)
Table 16 Global Viral Inactivation Market Analysis, by Cellular and Gene Therapy Products, (2017-2027) ($MN)
Table 17 Global Viral Inactivation Market Analysis, by Blood and Blood Products, (2017-2027) ($MN)
Table 18 Global Viral Inactivation Market Analysis, by End User, (2017-2027) ($MN)
Table 19 Global Viral Inactivation Market Analysis, by Pharmaceutical and Biotechnology Companies, (2017-2027) ($MN)
Table 20 Global Viral Inactivation Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 21 Global Viral Inactivation Market Analysis, by Contract Research Organizations, (2017-2027) ($MN)
Table 22 Global Viral Inactivation Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 23 Global Viral Inactivation Market Analysis, by Academic Research Institutes, (2017-2027) ($MN)
Table 24 North America Viral Inactivation Market Analysis, by Country, (2017-2027) ($MN)
Table 25 North America Viral Inactivation Market Analysis, by Product, (2017-2027) ($MN)
Table 26 North America Viral Inactivation Market Analysis, by Viral Inactivation Systems and Accessories, (2017-2027) ($MN)
Table 27 North America Viral Inactivation Market Analysis, by Services, (2017-2027) ($MN)
Table 28 North America Viral Inactivation Market Analysis, by Kits and Reagents, (2017-2027) ($MN)
Table 29 North America Viral Inactivation Market Analysis, by Method, (2017-2027) ($MN)
Table 30 North America Viral Inactivation Market Analysis, by Solvent Detergent Method, (2017-2027) ($MN)
Table 31 North America Viral Inactivation Market Analysis, by Radiation method, (2017-2027) ($MN)
Table 32 North America Viral Inactivation Market Analysis, by pH Concentration method, (2017-2027) ($MN)
Table 33 North America Viral Inactivation Market Analysis, by Pasteurization, (2017-2027) ($MN)
Table 34 North America Viral Inactivation Market Analysis, by Alkylating agent method, (2017-2027) ($MN)
Table 35 North America Viral Inactivation Market Analysis, by Application, (2017-2027) ($MN)
Table 36 North America Viral Inactivation Market Analysis, by Vaccines and Therapeutics, (2017-2027) ($MN)
Table 37 North America Viral Inactivation Market Analysis, by Tissues and Tissue Products, (2017-2027) ($MN)
Table 38 North America Viral Inactivation Market Analysis, by Stem Cell Products, (2017-2027) ($MN)
Table 39 North America Viral Inactivation Market Analysis, by Cellular and Gene Therapy Products, (2017-2027) ($MN)
Table 40 North America Viral Inactivation Market Analysis, by Blood and Blood Products, (2017-2027) ($MN)
Table 41 North America Viral Inactivation Market Analysis, by End User, (2017-2027) ($MN)
Table 42 North America Viral Inactivation Market Analysis, by Pharmaceutical and Biotechnology Companies, (2017-2027) ($MN)
Table 43 North America Viral Inactivation Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 44 North America Viral Inactivation Market Analysis, by Contract Research Organizations, (2017-2027) ($MN)
Table 45 North America Viral Inactivation Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 46 North America Viral Inactivation Market Analysis, by Academic Research Institutes, (2017-2027) ($MN)
Table 47 Europe Viral Inactivation Market Analysis, by Country, (2017-2027) ($MN)
Table 48 Europe Viral Inactivation Market Analysis, by Product, (2017-2027) ($MN)
Table 49 Europe Viral Inactivation Market Analysis, by Viral Inactivation Systems and Accessories, (2017-2027) ($MN)
Table 50 Europe Viral Inactivation Market Analysis, by Services, (2017-2027) ($MN)
Table 51 Europe Viral Inactivation Market Analysis, by Kits and Reagents, (2017-2027) ($MN)
Table 52 Europe Viral Inactivation Market Analysis, by Method, (2017-2027) ($MN)
Table 53 Europe Viral Inactivation Market Analysis, by Solvent Detergent Method, (2017-2027) ($MN)
Table 54 Europe Viral Inactivation Market Analysis, by Radiation method, (2017-2027) ($MN)
Table 55 Europe Viral Inactivation Market Analysis, by pH Concentration method, (2017-2027) ($MN)
Table 56 Europe Viral Inactivation Market Analysis, by Pasteurization, (2017-2027) ($MN)
Table 57 Europe Viral Inactivation Market Analysis, by Alkylating agent method, (2017-2027) ($MN)
Table 58 Europe Viral Inactivation Market Analysis, by Application, (2017-2027) ($MN)
Table 59 Europe Viral Inactivation Market Analysis, by Vaccines and Therapeutics, (2017-2027) ($MN)
Table 60 Europe Viral Inactivation Market Analysis, by Tissues and Tissue Products, (2017-2027) ($MN)
Table 61 Europe Viral Inactivation Market Analysis, by Stem Cell Products, (2017-2027) ($MN)
Table 62 Europe Viral Inactivation Market Analysis, by Cellular and Gene Therapy Products, (2017-2027) ($MN)
Table 63 Europe Viral Inactivation Market Analysis, by Blood and Blood Products, (2017-2027) ($MN)
Table 64 Europe Viral Inactivation Market Analysis, by End User, (2017-2027) ($MN)
Table 65 Europe Viral Inactivation Market Analysis, by Pharmaceutical and Biotechnology Companies, (2017-2027) ($MN)
Table 66 Europe Viral Inactivation Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 67 Europe Viral Inactivation Market Analysis, by Contract Research Organizations, (2017-2027) ($MN)
Table 68 Europe Viral Inactivation Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 69 Europe Viral Inactivation Market Analysis, by Academic Research Institutes, (2017-2027) ($MN)
Table 70 Asia Pacific Viral Inactivation Market Analysis, by Country, (2017-2027) ($MN)
Table 71 Asia Pacific Viral Inactivation Market Analysis, by Product, (2017-2027) ($MN)
Table 72 Asia Pacific Viral Inactivation Market Analysis, by Viral Inactivation Systems and Accessories, (2017-2027) ($MN)
Table 73 Asia Pacific Viral Inactivation Market Analysis, by Services, (2017-2027) ($MN)
Table 74 Asia Pacific Viral Inactivation Market Analysis, by Kits and Reagents, (2017-2027) ($MN)
Table 75 Asia Pacific Viral Inactivation Market Analysis, by Method, (2017-2027) ($MN)
Table 76 Asia Pacific Viral Inactivation Market Analysis, by Solvent Detergent Method, (2017-2027) ($MN)
Table 77 Asia Pacific Viral Inactivation Market Analysis, by Radiation method, (2017-2027) ($MN)
Table 78 Asia Pacific Viral Inactivation Market Analysis, by pH Concentration method, (2017-2027) ($MN)
Table 79 Asia Pacific Viral Inactivation Market Analysis, by Pasteurization, (2017-2027) ($MN)
Table 80 Asia Pacific Viral Inactivation Market Analysis, by Alkylating agent method, (2017-2027) ($MN)
Table 81 Asia Pacific Viral Inactivation Market Analysis, by Application, (2017-2027) ($MN)
Table 82 Asia Pacific Viral Inactivation Market Analysis, by Vaccines and Therapeutics, (2017-2027) ($MN)
Table 83 Asia Pacific Viral Inactivation Market Analysis, by Tissues and Tissue Products, (2017-2027) ($MN)
Table 84 Asia Pacific Viral Inactivation Market Analysis, by Stem Cell Products, (2017-2027) ($MN)
Table 85 Asia Pacific Viral Inactivation Market Analysis, by Cellular and Gene Therapy Products, (2017-2027) ($MN)
Table 86 Asia Pacific Viral Inactivation Market Analysis, by Blood and Blood Products, (2017-2027) ($MN)
Table 87 Asia Pacific Viral Inactivation Market Analysis, by End User, (2017-2027) ($MN)
Table 88 Asia Pacific Viral Inactivation Market Analysis, by Pharmaceutical and Biotechnology Companies, (2017-2027) ($MN)
Table 89 Asia Pacific Viral Inactivation Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 90 Asia Pacific Viral Inactivation Market Analysis, by Contract Research Organizations, (2017-2027) ($MN)
Table 91 Asia Pacific Viral Inactivation Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 92 Asia Pacific Viral Inactivation Market Analysis, by Academic Research Institutes, (2017-2027) ($MN)
Table 93 South America Viral Inactivation Market Analysis, by Country, (2017-2027) ($MN)
Table 94 South America Viral Inactivation Market Analysis, by Product, (2017-2027) ($MN)
Table 95 South America Viral Inactivation Market Analysis, by Viral Inactivation Systems and Accessories, (2017-2027) ($MN)
Table 96 South America Viral Inactivation Market Analysis, by Services, (2017-2027) ($MN)
Table 97 South America Viral Inactivation Market Analysis, by Kits and Reagents, (2017-2027) ($MN)
Table 98 South America Viral Inactivation Market Analysis, by Method, (2017-2027) ($MN)
Table 99 South America Viral Inactivation Market Analysis, by Solvent Detergent Method, (2017-2027) ($MN)
Table 100 South America Viral Inactivation Market Analysis, by Radiation method, (2017-2027) ($MN)
Table 101 South America Viral Inactivation Market Analysis, by pH Concentration method, (2017-2027) ($MN)
Table 102 South America Viral Inactivation Market Analysis, by Pasteurization, (2017-2027) ($MN)
Table 103 South America Viral Inactivation Market Analysis, by Alkylating agent method, (2017-2027) ($MN)
Table 104 South America Viral Inactivation Market Analysis, by Application, (2017-2027) ($MN)
Table 105 South America Viral Inactivation Market Analysis, by Vaccines and Therapeutics, (2017-2027) ($MN)
Table 106 South America Viral Inactivation Market Analysis, by Tissues and Tissue Products, (2017-2027) ($MN)
Table 107 South America Viral Inactivation Market Analysis, by Stem Cell Products, (2017-2027) ($MN)
Table 108 South America Viral Inactivation Market Analysis, by Cellular and Gene Therapy Products, (2017-2027) ($MN)
Table 109 South America Viral Inactivation Market Analysis, by Blood and Blood Products, (2017-2027) ($MN)
Table 110 South America Viral Inactivation Market Analysis, by End User, (2017-2027) ($MN)
Table 111 South America Viral Inactivation Market Analysis, by Pharmaceutical and Biotechnology Companies, (2017-2027) ($MN)
Table 112 South America Viral Inactivation Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 113 South America Viral Inactivation Market Analysis, by Contract Research Organizations, (2017-2027) ($MN)
Table 114 South America Viral Inactivation Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 115 South America Viral Inactivation Market Analysis, by Academic Research Institutes, (2017-2027) ($MN)
Table 116 Middle East & Africa Viral Inactivation Market Analysis, by Country, (2017-2027) ($MN)
Table 117 Middle East & Africa Viral Inactivation Market Analysis, by Product, (2017-2027) ($MN)
Table 118 Middle East & Africa Viral Inactivation Market Analysis, by Viral Inactivation Systems and Accessories, (2017-2027) ($MN)
Table 119 Middle East & Africa Viral Inactivation Market Analysis, by Services, (2017-2027) ($MN)
Table 120 Middle East & Africa Viral Inactivation Market Analysis, by Kits and Reagents, (2017-2027) ($MN)
Table 121 Middle East & Africa Viral Inactivation Market Analysis, by Method, (2017-2027) ($MN)
Table 122 Middle East & Africa Viral Inactivation Market Analysis, by Solvent Detergent Method, (2017-2027) ($MN)
Table 123 Middle East & Africa Viral Inactivation Market Analysis, by Radiation method, (2017-2027) ($MN)
Table 124 Middle East & Africa Viral Inactivation Market Analysis, by pH Concentration method, (2017-2027) ($MN)
Table 125 Middle East & Africa Viral Inactivation Market Analysis, by Pasteurization, (2017-2027) ($MN)
Table 126 Middle East & Africa Viral Inactivation Market Analysis, by Alkylating agent method, (2017-2027) ($MN)
Table 127 Middle East & Africa Viral Inactivation Market Analysis, by Application, (2017-2027) ($MN)
Table 128 Middle East & Africa Viral Inactivation Market Analysis, by Vaccines and Therapeutics, (2017-2027) ($MN)
Table 129 Middle East & Africa Viral Inactivation Market Analysis, by Tissues and Tissue Products, (2017-2027) ($MN)
Table 130 Middle East & Africa Viral Inactivation Market Analysis, by Stem Cell Products, (2017-2027) ($MN)
Table 131 Middle East & Africa Viral Inactivation Market Analysis, by Cellular and Gene Therapy Products, (2017-2027) ($MN)
Table 132 Middle East & Africa Viral Inactivation Market Analysis, by Blood and Blood Products, (2017-2027) ($MN)
Table 133 Middle East & Africa Viral Inactivation Market Analysis, by End User, (2017-2027) ($MN)
Table 134 Middle East & Africa Viral Inactivation Market Analysis, by Pharmaceutical and Biotechnology Companies, (2017-2027) ($MN)
Table 135 Middle East & Africa Viral Inactivation Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 136 Middle East & Africa Viral Inactivation Market Analysis, by Contract Research Organizations, (2017-2027) ($MN)
Table 137 Middle East & Africa Viral Inactivation Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 138 Middle East & Africa Viral Inactivation Market Analysis, by Academic Research Institutes, (2017-2027) ($MN)